Science by any other name is still…politics?
Without further commentary I offer for your consideration the concluding remarks of an American Heart Association “scientific statement“ [my emphasis] published yesterday:
The debate about the increased risk of cardiovascular events attributed to the selective COX-2 inhibitors and the nonselective NSAIDs is part of a broader national debate about drug safety. Optimal safety evaluation of drugs requires timely and complete submission of scientific data from the manufacturers, as well as increased funding and authority granted to the FDA by Congress.
